RxDoctor Payments Data

Heidi Essig, PA

Medical · Birmingham, ALNPI 1265547137

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,659, 2.5 times the $1,055 reported in 2021. Among medical clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,169in general payments, 2019–2025

Across 369 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$1K
  • AbbVie$823
  • Novartis$619
  • Incyte Corporation$608
  • Dermavant Sciences, Inc.$601
  • Sun Pharmaceutical Industries Inc.$522
  • plus $4K from 19 others

What the payments were for

  • Food & beverage$7,67194%
  • Education$4986%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,169 in reported general payments places this provider in the 90th percentile of 175 medical providers in Alabama.

See all medical providers in Alabama

Medicare billing

Part B allowed, 2024
$116,050
Medicare patients
596
Services billed
2,637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$299,240
Dupixent PenDupilumab69$285,631
Fluorouracil130$10,136
Tacrolimus41$9,224
Clobetasol Propionate96$5,548
Metronidazole27$1,973
Ketoconazole95$1,718
Glycopyrrolate12$1,362
CiclopiroxCiclopirox Olamine27$1,267
Clindamycin Phosphate26$1,250
Betamethasone Dipropionate25$1,178
Doxycycline Monohydrate28$1,087
Doxycycline Hyclate37$1,038
Triamcinolone Acetonide97$990
ValacyclovirValacyclovir Hcl39$882

Paid to pharmacies, not to this prescriber.

Other medical in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →